Virologists at the Rega Institute at KU Leuven (Belgium) have developed a vaccine candidate against Covid-19 based on the yellow fever vaccine, which as a result also works against yellow fever. Results...

By NewsDesk  @bactiman63 Specialty vaccine company, Valneva SE, announced yesterday its plans to accelerate pediatric development of its Lyme vaccine candidate, VLA15, in collaboration with Pfizer Inc.,...

By NewsDesk   @bactiman63 Pfizer Inc. and BioNTech SE announced today that the Medicines & Healthcare Products Regulatory Agency (MHRA) in the U.K. has granted a temporary authorization for emergency...

By NewsDesk  @bactiman63 An experimental vaccine developed in Europe to prevent infection by Crimean-Congo hemorrhagic fever virus (CCHFV) has protected cynomolgus macaques in a new collaborative study...

By NewsDesk  @bactiman63 Massachusetts based biotechnology company, Moderna, announced today that the primary efficacy analysis of the Phase 3 study of mRNA-1273 conducted on 196 cases confirms the high...

By NewsDesk  @bactiman63 The United Nations Office for the Coordination of Humanitarian Affairs (OCHA) has reported updates on two important vaccination campaigns in the north-central Africa nation...

By NewsDesk  @bactiman63 Public Health England reported this week three-quarters (75%) of those aged 65 and over in England received the free vaccine so far this year – up from 72.4% at the end of...

By NewsDesk  @bactiman63 Fiji’s national vaccine program against pneumonia, a serious lung condition, and rotavirus, a common disease which causes severe diarrhoea and vomiting, has reduced illness...

Vaccitech’s scientific founders at University of Oxford announce positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil. Phase 3 interim analysis including...

By NewsDesk  @bactiman63 Vivaldi Biosciences, a clinical-stage biotechnology company developing genetically engineered intranasal vaccines for viral respiratory diseases, today announced it has filed...